(Updated - April 20, 2018 6:54 AM EDT)Biogen (NASDAQ: BIIB) and Ionis Pharmaceuticals (NASDAQ: IONS) announced today they have expanded ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Hot Corp. News Hot FDA News Management Comments

Ionis Pharma (IONS) Highlights Top-Line Data from Phase 1/2 Study of ONIS-HTTRx (RG6042) at AAN MeetingsApril 24, 2018 12:17 PM Piper Jaffray Remains Bullish on Biogen (BIIB) Following 1Q April 24, 2018 8:48 AM Biogen (BIIB) Tops Q1 EPS by 13c, Miss on RevenuesApril 24, 2018 7:00 AM Nomura/Instinet Reiterates Buy on Biogen (BIIB) Following Announced IONS Collaboration April 23, 2018 8:14 AM Biogen (BIIB) Reports New SPINRAZA (nusinersen) Data at AAN MeetingsApril 23, 2018 7:33 AM Ionis Pharmaceuticals (IONS) PT Raised to $75 at BMO Capital on Expanded Biogen DealApril 20, 2018 9:51 AM Biogen and Ionis Expand Strategic Collaboration to Develop Drug Candidates for a Broad Range of Neurological DiseasesApril 20, 2018 6:30 AM Biogen (BIIB) Missed Out on AveXis (AVXS) But Well-Positioned for Substantial Acquisition - RBCApril 18, 2018 1:59 PM AveXis (AVXS) Was a Buyout Target Before It's IPO and Had Three Other Companies Interested Before Mega Novartis DealApril 18, 2018 12:25 PM